June 3, 2025

Addus HomeCare Corporation (ADUS) Stock Analysis: Exploring a 22% Upside Potential in the Healthcare Sector

Addus HomeCare Corporation (NASDAQ: ADUS), a leader in the healthcare sector, is capturing the attention of investors with its promising 22.39% upside potential, according to the..

ImmunityBio, Inc. (IBRX) Investor Outlook: A Promising 326.97% Upside in Biotechnology

ImmunityBio, Inc. (NASDAQ: IBRX) is capturing the attention of investors with its impressive potential upside of 326.97%, as indicated by analyst ratings. This commercial-stage biotechnology company,..

Recursion Pharmaceuticals, Inc. (RXRX): Investor Outlook with a 69.99% Potential Upside

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to drug discovery. With a market..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: 114% Potential Upside Captivates Investor Attention

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical innovator in the healthcare sector, has captured the attention of investors with a remarkable potential upside of 114.76%. As..

Structure Therapeutics Inc. (GPCR): Analyst Consensus Highlights a Potential 250% Upside for This Biotech Stock

Structure Therapeutics Inc. (NASDAQ: GPCR), a promising player in the biotechnology sector, is catching the eyes of investors with a substantial market capitalization of $1.25 billion...

ACADIA Pharmaceuticals Inc. (ACAD) Investor Outlook: Targeting a 24% Upside with CNS Innovations

ACADIA Pharmaceuticals Inc. (ACAD), a prominent player in the biotechnology sector, is gaining attention for its innovative focus on central nervous system (CNS) disorders and rare..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Unlocking a 29.98% Potential Upside in Healthcare Innovation

LeMaitre Vascular, Inc. (LMAT), a prominent player in the healthcare sector, specializes in medical instruments and supplies, focusing on innovative solutions for vascular surgery. With a..

Kiniksa Pharmaceuticals (KNSA) Stock Analysis: 36.1% Upside Potential Captivates Investors

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA), a promising player in the healthcare sector, offers a compelling investment opportunity with a potential upside of 36.1%, as suggested by..

Galapagos NV (GLPG) Stock Analysis: Navigating the Biotech Landscape with Potential Risks and Rewards

Galapagos NV (NASDAQ: GLPG), a prominent player in the biotechnology sector, is capturing attention with its focus on oncology and immunology. While the company is based..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring a 121% Potential Upside for Investors

CRISPR Therapeutics AG (NASDAQ: CRSP) is generating significant buzz in the biotechnology sector with its pioneering approach to gene editing. The company, headquartered in Zug, Switzerland,..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: A 26.61% Upside Potential Amidst Healthcare Challenges

In the ever-evolving landscape of healthcare, Pediatrix Medical Group, Inc. (NYSE: MD) stands out as a significant player, providing a wide range of specialized medical services..

Merus N.V. (MRUS) Stock Analysis: Unveiling a 51% Potential Upside in Biotech Innovation

Merus N.V. (NASDAQ: MRUS), a pivotal player in the biotechnology sector, is capturing the attention of investors with its promising pipeline and impressive market metrics. Headquartered..

Astrana Health Inc. (ASTH) Investor Outlook: Unpacking a 104.49% Potential Upside

Astrana Health Inc. (NASDAQ: ASTH), a prominent player in the healthcare sector, is capturing the attention of investors with its robust growth metrics and a staggering..

Arcellx, Inc. (ACLX) Investor Outlook: Biotechnology Stock with 80.10% Potential Upside

For investors seeking opportunities in the biotechnology sector, Arcellx, Inc. (NASDAQ: ACLX) presents a compelling case with a significant potential upside. Headquartered in Redwood City, California,..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Exploring a 60% Upside Potential in Biotech Innovation

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a key player in the biotechnology sector, is attracting attention with its innovative focus on cellular metabolism and a potential upside..

Neogen Corporation (NEOG) Stock Analysis: Healthcare Innovator with a 58% Potential Upside

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector, particularly within the diagnostics and research industry, presents intriguing opportunities for investors looking to capitalize..

Metsera, Inc. (MTSR) Stock Analysis: Exploring a Robust 67% Potential Upside in the Biotech Sector

Metsera, Inc. (MTSR), a promising player in the biotechnology sector, is attracting significant attention from investors eyeing the healthcare space. Based in New York and incorporated..

Teladoc Health, Inc. (TDOC) Investor Outlook: Navigating the Virtual Care Landscape with a 30% Upside Potential

Teladoc Health, Inc. (TDOC), a leader in the burgeoning field of virtual healthcare services, continues to capture investor interest despite recent financial challenges. With a market..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Exploring the 31.52% Upside Potential

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN), a prominent player in the healthcare sector, operates within the Medical Care Facilities industry, focusing on providing specialized pharmacy services..

Surgery Partners, Inc. (SGRY): Investor Outlook with a Promising 34% Potential Upside

Surgery Partners, Inc. (NASDAQ: SGRY), a major player in the U.S. healthcare sector, particularly in the medical care facilities industry, is drawing significant attention from investors..

Search

Funds

June 3, 2025

Search

Funds

June 3, 2025

FTSE 100

Funds